ArticlePDF Available

A STUDY ON ANALYSING PREDICTIVE FACTORS FOR MAJOR LOWER EXTREMITY AMPUTATION IN DIABETIC FOOT PATIENTS

Authors:
  • Thanjavur medical college and hospital

Abstract

Diabetic foot is defined by World Health Organisation as “The foot of a Diabetes mellitus patient that has the potential risk of pathologic consequences, including infection, ulceration, and/or destruction of deep tissues associated with neurologic abnormalities, various degrees of peripheral vascular diseases and/or metabolic complications of diabetes in lower limb”. The objective of our study is to analyse various clinical and pathological factors which contribute to major amputations of the lower extremities in diabetic foot patients and to determine the influence of each factor in the final therapeutic outcome. This study was conducted on 100 cases of diabetic foot ulcer patients admitted to Thanjavur Medical College Hospital during a period of 10 months from February 2018 to November 2018. The cases were all proven diabetics suffering from ulcers of the foot. Of the total 100 patients who were studied, 57% were managed conservatively. The overall amputation rate was 43% with 27 patients undergoing major amputations (22 below knee amputations and 5 above knee amputations) and 16 patients having to undergo minor amputations (13 digital ray-amputations and 3 tarsometatarsal amputations). This study has demonstrated that old age, male gender, the presence of gangrene, absence of pulsations of the affected limb, osteomyelitis, longer duration of diabetes, increased total leucocyte count (TLC), higher Wagner's grading of ulcer (grade 3 or more), low hemoglobin and soft tissue infection are adverse predictive factors for major lower extremity amputation in diabetic foot patients.
A STUDY ON ANALYSING PREDICTIVE FACTORS FOR MAJOR LOWER
EXTREMITY AMPUTATION IN DIABETIC FOOT PATIENTS
Premalatha
Sharon Rose
Associate Professor, Department of General Surgery, Thanjavur Medical College
Hospital Thanjavur- 613004
Original Research Paper
General Surgery
INTRODUCTION AND AIM:
Diabetic foot encompasses a constellation of syndromes, in which the
cumulative effects of neuropathy, ischaemia and infection lead to
tissue breakdown. Global prevalence of diabetes in 2003 was
estimated to be 194 million. By 2030, this figure is expected to rise to
an astronomical 366 million due to longer life expectancy and
changing dietary habits. India, with its oncoming diabetic epidemic
and increasing geriatric population, has shown an upsurge in the in the
incidence of peripheral vascular disease. Gangrene and ulcers
preceding amputations are largely preventable through awareness
generated by health education and organized foot care programmes.
Diabetes-related peripheral vascular disease and foot ulcers constitute
a significant percentage of hospital admissions and this is of great
socio-economic importance as majority of them are in the prime
earning age group and are poor. The management of treating foot
ulcers is rig orous and entails fre quent surgical consult atio ns,
expensive drugs, repeated investigations, dressings and procedures
and this proves to be beyond the reach of most of the Indian population
which struggles to have daily ends met. Various research papers
published world over have demonstrated that the reaching out
approach has dramatically reduced amputation rates and this is more
impactful than tertiary care. Early detection and attention to warning
signs can surely avert amputations and its attending repercussions,
both socio-economic and personal. Lower limb ischaemia in diabetes
due to ma croa ngio pathy causes non-healing ulce rs, infection,
ampu tation and even mor tality. Foot ulce ration is absol utely
preventable and by simple interventions one can reduce amputations
rates in up to 80% of patients. Regular evaluation and early treatment
are the most effective mechanisms to prevent the devastating diabetic
foot complications.
This study was conducted to analyse the predictive factors (clinical and
pathological) for major lower extremity amputation in diabetic foot
patients.
MATERIALS AND METHODS:-
Study was conducted on 100 cases of diabetic foot ulcer patients
admitted to Thanjavur Medical College Hospital during a period of 10
months from February 2018 to November 2018. The cases were all
proven diabetics suffering from lower limb ulcers secondary to
Diabetes Mellitus and were evaluated for various clinical and
pathological factors which were thought likely to favourably or
adversely influence the prognosis of diabetic foot ulcers. All values
were analysed using percentages and tabulated for comparison.
INCLUSION CRITERIA:
Ÿ All patients aged 12 years or more with diabetic foot ulcers.
EXCLUSION CRITERIA:
Ÿ Paediatric age group less than 12 years.
Ÿ Immunocompromised states like HIV, TB, and malignancy.
Ÿ Those who expired at the time of admission.
RESULTS AND OBSERVATIONS
AGE DISTRIBUTION:
The youngest patient was 32 years old, and eldest was 80 years old.
Highest number of cases were found in the age group of 51-70 years.
SEX DISTRIBUTION:
Out of 100 patients, 58 were male and 42 were females. Males are more
commonly affected by diabetic foot disease and amputation rates are
also higher compared to females.
Diabetic foot is defined by World Health Organisation as “The foot of a Diabetes mellitus patient that has the potential risk
of pathologic consequences, including infection, ulceration, and/or destruction of deep tissues associated with neurologic
abnormalities, various degrees of peripheral vascular diseases and/or metabolic complications of diabetes in lower limb”. The objective of our
study is to analyse various clinical and pathological factors which contribute to major amputations of the lower extremities in diabetic foot
patients and to determine the influence of each factor in the final therapeutic outcome. This study was conducted on 100 cases of diabetic foot
ulcer patients admitted to Thanjavur Medical College Hospital during a period of 10 months from February 2018 to November 2018. The cases
were all proven diabetics suffering from ulcers of the foot. Of the total 100 patients who were studied, 57% were managed conservatively. The
overall amputation rate was 43% with 27 patients undergoing major amputations (22 below knee amputations and 5 above knee amputations) and
16 patients having to undergo minor amputations (13 digital ray-amputations and 3 tarsometatarsal amputations). This study has demonstrated
that old age, male gender, the presence of gangrene, absence of pulsations of the affected limb, osteomyelitis, longer duration of diabetes,
increased total leucocyte count (TLC), higher Wagner's grading of ulcer (grade 3 or more), low hemoglobin and soft tissue infection are adverse
predictive factors for major lower extremity amputation in diabetic foot patients.
ABSTRACT
Volume - 10 | Issue - 11 | November - 2020 | . PRINT ISSN No 2249 - 555X | DOI : 10.36106/ijar
KEYWORDS : Gangrene, Wagner, Osteomyelitis
Thivagar
Thirugnanam
Assistant Professor, Department of General Surgery, Thanjavur Medical College
Hospital Thanjavur- 613004
Navin Sundar*
Junior Resident, Department of General Surgery, Thanjavur Medical College Hospital
Thanjavur- 613004.*Corresponding Author
INDIAN JOURNAL OF APPLIED RESEARCH
35
Volume - 10 | Issue - 11 | November - 2020 | . PRINT ISSN No 2249 - 555X | DOI : 10.36106/ijar
DURATION OF DIABETES MELLITUS:
Over 70% of major amputations involved patients with longer duration
of diabetes mellitus.
PRESENCE OF GANGRENE:
100% of patients with complete gangrene ended up in major or minor
amputations with 58.33% patients needing major amputations.
PULSE STATUS OF THE AFFECTED PART:
100 % of patients with absent pulse went for major amputations.
Osteomyelitis:
All 7 patients with osteomyelitis had to undergo amputation.
INFECTIONS:
Out of 27 amputations, 24 (89%) were infected with microorganisms.
Gangrene
Number
of
patients
Major
Amputat
ions
Minor
Amputat
ions
Minor
amputat
ion%
Conservative
Management
%
Present
26
15
11
42.31%
0%
Absent
74
12
5
6.75%
77.04%
Pulsations
Number
of
patients
Major
Amput
ation
Minor
Amput
ation
Major
amputat
ion%
Minor
amputation
%
Conservative
Management
%
Absent
22
22
0
100%
0%
0%
Present
78
5
16
6.40%
20.53%
73.07%
Osteomyel
itis
Numb
er of
Patien
ts
Major
Amputati
on
Minor
Amputati
on
Major
Amputati
on%
Minor
Amputati
on%
Conservat
ive
Managem
ent %
Present
7
3
4
42.85%
57.15%
0%
Bacterial
Culture
No of
Patients
Major
Amputations
Minor
Amputations
Major
Amputations%
Minor
Amputations%
Conservative Management%
Positive
24
14
6
58.33%
25%
16.67%
Negative
76
13
10
17.10%
13.15%
69.75%
Grade
Number of
Patients
Major
Amputations
Minor
Amputations
Major
Amputations%
Minor
Amputations%
Conservative%
1
04
0
0
0%
0%
100%
2
53
0
0
0%
0%
100%
3
14
12
2
85.72%
14.28%
0%
4
24
10
14
41.67%
58.33%
0%
5
5
5
0
100%
0%
0%
Common organisms were St aph ylococcus aur eus, Klebs iel la,
Pseudomonas, E. coli and Proteus.
GRADING OF ULCER:
Patients were arbitrarily divided into two groups according to
Wagne r's Gr adi ng sys tem (low grade 0-2; H igh grade 3-5).
Amputation rates were higher in Grade 3 and above.
Total Leucocyte Count (TLC):
HAEMOGLOBIN:
An analysis of 100 cases of diabetic foot was done. These cases were
treated in different surgical units in the department of general surgery,
Thanjavur Medical College Hospital. Of the total 100 patients who
were studied, 57 were managed conservatively with 27 patients
undergoing major amputations (22 below knee amputations and 5
above knee amputations) and 16 patients having to undergo minor
amputations (13 digital ray-amputations and 3 tarsometatarsal
amputations).
DISCUSSION:
Of the total of 100 patients who were studied, 57 were managed
conservatively with 27 patients undergoing major amputations (22
below knee amputations and 5 above knee amputations) and 16
patients having to undergo minor amputations (13 digital ray-
amputations and 3 tarsometatarsal amputations). Most of the patients
in this study presented when infection or gangrene had already set in.
In this study, the major amputation rate in diabetic patients was as high
as 27%. Male patients had a slightly higher rate of major amputations
(16%) relative to female patients (5%). The major amputations were
common in patients in their 5th-7th decades of age (16%). Positive
bacterial cultures lead to significantly higher rates of major amputation
with 58% of those showing organisms on culture needing major
amputations. Presence of gangrene warranted major amputation in
58% patients and absence of peripheral pulses led to all patients having
major amputations. Wagner's grading III- V was associated with higher
rates of major amputations (86%, 42% and 100% for grades III, IV and
V respectively). In this study, major amputation rates increased in
patients having diabetes for more than 3 years (70%), possibly owing
to worsening of arteriopathy. All seven patients with foot ulcers having
oste omye litis ended up having major (43 %) o r mi nor (57%)
amputations. We have observed that higher levels of total leucocyte
count (TLC) due to infection increases the rate of major amputation by
eight times (24% in patients with TLC >12,000 against 3% in patients
with TLC< 12,000). And amputation tendency increases with fall in
haemoglobin level with 45% of patients with Hb< 10gm needing major
amputations possibly attributed to diminished oxygen supply in an
already ischemic limb.
CONCLUSION:
This study shows that old age, male gender, absence of pulsations,
presence of infection, longer duration of disease, osteomyelitis,
presence of gangrene, higher grade of Wagner's severity classification,
leukocytosis, low hemoglobin were independent adverse predictors of
major lower extremity amputation rates in diabetic foot patients. The
care of the diabetic foot thus takes place at 3 levels; the patient must
take routine measures to take care of his/her foot with early lesions
getting quick attention from a podiatrist and advanced lesions
requiring early specialised care.
Hemogl
obin
gm%
Number
of
patients
Major
Amputa
tions
Minor
Amput
ations
Major
Amputati
ons%
Minor
Amputa
tions%
Conservati
ve
Manageme
nt%
<10gm
%
36
16
9
44.45%
25%
30.55%
>10gm
%
64
11
7
17.18%
10.93%
71.89%
36
INDIAN JOURNAL OF APPLIED RESEARCH
ACKNOWLEDGEMENTS: None
REFERENCES:
1. Katsilambros N, Makrilakis K, Tentolouris N, Tsapogas P. Diabetic foot. In: Liapis CD,
Balzer K, Valentini FB, Fernandes J editors. Vascular surgery. Berlin: Springer; 2007;
Pp. 501-21.
2. Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the
prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice.
2011;94(3):311-21.
3. Gupta S. Management of diabetic foot. Medicine Update. 2012;22:28793.
4. Umpierrez GE, Zlatev T, Spanheimer RG. Correction of altered collagen metabolism in
diabetic animals with insulin therapy. Matrix.1989;9(4):336-42.
5. Pendsey S. Reducing diabetic foot problems and limb amputation: An experiencefrom
India. In: Dinh T, editor. Global Perspective on Diabetic Foot Ulcerations. Croatia:
InTech; 2011. Pp. 15-24.
6. Oyibo SO, Jude EB, Tarawneh I, Nguyen HC, Harkless LB, Boulton AJMM. A
Comparison of Two Diabetic Foot Ulcer Classification Systems: The Wagner and the
University of Texas wound classification systems. Diabetes Care. 2001;24(1):84-8.
7. Zubair M, Malik A, Ahmad J. Incidence, risk factors for amputation among patients with
diabetic foot ulcer in a North Indian tertiary care hospital. Foot. 2012;22:24-30.
8. Adler AI, Boyko EJ, Ahroni JH, Smith DG. Lower-extremity amputation in diabetes.
The independent effects of peripheral vascular disease, sensory neuropathy, and foot
ulcers. Diabetes Care. 1999;22(7):1029-35.
9. Chuan F, Zhang M, Yao Y, Tian W, He X, Zhou B. Anemia in patients with diabetic foot
ulcer. Int J Low Extrem Wounds. 2016; 15:220–6.
10. International Diabetes Federation. Time to Act: diabetes and foot care. Brussels
International Diabetes Federation 2005.
11. Campbell WB, Ponette D, Sugiono M. Longterm results following operation for diabetic
foot problems: arterial disease confers a poor prognosis. Eur J Vasc Surg 2000;19:174–7.
12. Ramsey SD, Newton K, Blough D, et al. Incidence , Outcome and Foot ulcers in patients
with diabetes. Diabetes care 1999;22:382-387.
13. Vijay V, Satyavani K, SaraswathyGnanasundaram, Gautham G, Bhabendranath D. The
Jour of Diab Foot Complications. Open access publishing on June 30th 2009;1:40 – 46.
14. Shobhana R, Rama Rao P, Lavanya A, Vijay V, Ramachandran A. Cost burden to
Diabetic patients with foo t complications- a study from South ern India. JAPI
2000;48:12.
Volume - 10 | Issue - 11 | November - 2020 | . PRINT ISSN No 2249 - 555X | DOI : 10.36106/ijar
INDIAN JOURNAL OF APPLIED RESEARCH
37
ResearchGate has not been able to resolve any citations for this publication.
Article
Full-text available
To determine the incidence of foot ulcers in a large cohort of patients with diabetes, the risk of developing serious complications after diagnosis, and the attributable cost of care compared with that in patients without foot ulcers. Retrospective cohort study of patients with diabetes in a large staff-model health maintenance organization from 1993 to 1995. Patients with diabetes were identified by algorithm using administrative, laboratory, and pharmacy records. The data were used to calculate incidence of foot ulcers, risk of osteomyelitis, amputation, and death after diagnosis of foot ulcer, and attributable costs in foot ulcer patients compared with patients without foot ulcers. Among 8,905 patients identified with type 1 or type 2 diabetes, 514 developed a foot ulcer over 3 years of observation (cumulative incidence 5.8%). On or after the time of diagnosis, 77 (15%) patients developed osteomyelitis and 80 (15.6%) required amputation. Survival at 3 years was 72% for the foot ulcer patients versus 87% for a group of age- and sex-matched diabetic patients without foot ulcers (P < 0.001). The attributable cost for a 40- to 65-year-old male with a new foot ulcer was $27,987 for the 2 years after diagnosis. The incidence of foot ulcers in this cohort of patients with diabetes was nearly 2.0% per year. For those who developed ulcers, morbidity, mortality, and excess care costs were substantial compared with those for patients without foot ulcers. The results appear to support the value of foot-ulcer prevention programs for patients with diabetes.
Article
Full-text available
To identify risk factors for lower-extremity amputation (LEA) in individuals with diabetes and to estimate the incidence of LEA. This is a prospective study of 776 U.S. veterans in a general medicine clinic in Seattle, Washington. The outcome was first LEA during follow-up. Potential risk factors evaluated in proportional hazards models included, among others, peripheral vascular disease (PVD), sensory neuropathy, former LEA, foot deformities and ulcers, diabetes duration and treatment, and hyperglycemia. Associated with an increased risk for LEA were PVD defined as transcutaneous oxygen < or = 50 mmHg (relative risk [RR] = 3.0, 95% CI 1.3-7.1), insensitivity to monofilament testing (RR = 2.9, odds ratio = 1.1-7.8), lower-extremity ulcers (RR = 2.5, CI 1.1-5.4), former LEA, and treatment with insulin when controlling for duration of diabetes and other factors in the model. PVD defined as absent or diminished lower-extremity pulses or an ankle arm index < or = 0.8 was also associated with a significantly higher risk of LEA in separate models. Foot ulcers were associated with an increased ipsilateral risk of amputation. The age-adjusted incidence among men only for LEA standardized to the 1991 U.S. male diabetic population was 11.3/1,000 patient-years. This prospective study shows that peripheral sensory neuropathy, PVD, foot ulcers (particularly if they appear on the same side as the eventual LEA), former amputation, and treatment with insulin are independent risk factors for LEA in patients with diabetes.
Article
Full-text available
In this study the following two ulcer classification systems were applied to new foot ulcers to compare them as predictors of outcome: the Wagner (grade) and the University of Texas (UT) (grade and stage) wound classification systems. Ulcer size, appearance, clinical evidence of infection, ischemia, and neuropathy at presentation were recorded, and patients were followed up until healing or for 6 months. Of 194 patients with new foot ulcers, 67.0% were neuropathic, 26.3% were neuroischemic, 1.0% were ischemic, and 5.7% had no identified underlying factors. Median (interquartile range [IQR]) ulcer size at presentation was 1.5 cm2 (0.6-4.0). Lower-limb amputations were performed for 15% of ulcers, whereas 65% healed [median (IQR) healing time 5 (3-10) weeks] and 16% were not healed at study termination; 4% of patients died. Wagner grade (P < 0.0001), and UT grade (P < 0.0001) and stage (P < 0.001) showed positive trends with increased number of amputations. For UT stage, the risk of amputation increased with infection both alone (odds ratio [OR] = 11.1, P < 0.0001) and in combination with ischemia (OR = 14.7, P < 0.0001), but not significantly with ischemia alone (OR = 4.6, P = 0.09). Healing times were not significantly different for each grade of the Wagner (P = 0.1) or the UT system (P = 0.07), but there was a significant stepwise increase in healing time with each stage of the UT system (P < 0.05), and stage predicted healing (P < 0.05). Increasing stage, regardless of grade, is associated with increased risk of amputation and prolonged ulcer healing time. The UT system's inclusion of stage makes it a better predictor of outcome.
Article
Full-text available
To study the economic burden of management of diabetes in patients with foot complications, as a large number of them suffer from foot complications of varying severity. This study relates to direct cost to diabetic patients with foot complications. An illustrative sample of 270 Type 2 diabetic subjects, 164 without foot complications (Control group, Group 1) and 106 with foot complications (Group 2) were studied. They were available for the study during a six month period from January to June 1998. Group 2 had two sub-groups, i.e., those who needed out-patient (OP) treatment only (n = 23) and those who needed treatment in the hospital (HP) (n = 83). The study subjects were interviewed personally by the educator to collect demographic data and treatment expenditure. Total median expenditure incurred by the diabetic subjects without foot complications (Group 1) was Rs. 4373/- and by those with foot complications (Group 2) was Rs. 15,450/-. Patients who required hospitalised treatment incurred higher expenses than the OP patients, towards doctor's fees and hospitalisation (P < 0.0001). The percent of total income spent by the HP patients was higher than by the OP patients (P < 0.02). Diabetic subjects with foot problems incur very heavy expenditure in the treatment process. Most of the direct costs of diabetes treatment results from its complications. The hospitalisation costs for the complications of diabetes are particularly heavy. This underscores the need to reduce complications and also their economic burden.
Article
Diabetes is an increasingly important condition globally and robust estimates of its prevalence are required for allocating resources. Data sources from 1980 to April 2011 were sought and characterised. The Analytic Hierarchy Process (AHP) was used to select the most appropriate study or studies for each country, and estimates for countries without data were modelled. A logistic regression model was used to generate smoothed age-specific estimates which were applied to UN population estimates for 2011. A total of 565 data sources were reviewed, of which 170 sources from 110 countries were selected. In 2011 there are 366 million people with diabetes, and this is expected to rise to 552 million by 2030. Most people with diabetes live in low- and middle-income countries, and these countries will also see the greatest increase over the next 19 years. This paper builds on previous IDF estimates and shows that the global diabetes epidemic continues to grow. Recent studies show that previous estimates have been very conservative. The new IDF estimates use a simple and transparent approach and are consistent with recent estimates from the Global Burden of Disease study. IDF estimates will be updated annually.
Article
Aim of this study was to evaluate the incidence and risk factors for amputation among patients with diabetic foot ulcer (DFU). We performed a prospective study of 162 DFU in patients treated in a multidisciplinary based diabetes and endocrinology centre of Jawaharlal Nehru Medical College of Aligarh Muslim University, Aligarh, India during the period of December 2008-March 2011. Detailed history and physical examination was carried out for every subject. Risk factors for amputation were determined by univariate analysis with 95% of CI. The overall amputation rate was 28.4%. On univariate analysis, male sex [OR 2.8, RR 1.28], hypertension [OR 2.83, RR 1.31], neuropathy [OR 3.01, RR 1.35], nephropathy [OR 2.24, RR 1.26], LDL-C (>100mg/dl) [OR 2.53, RR 1.28], total cholesterol (>150mg/dl) [OR 3.74, RR 1.52],HDLC(<40mg/dl) [OR 1.19, RR 1.18], triglycerides (>200mg/dl) [OR 5.44, RR1.76], previous antibiotic use [OR 9.12, RR 1.92], osteomyelitis [OR 6.97, RR 2.43] and biofilm infection [OR 4.52, RR 1.41] were significant risk factors. The risk factors for amputation were presence of PVD, leukocytosis, neuropathy, nephropathy, hypertension, dyslipidemia, over use of antibiotics, osteomyelitis, biofilm production and higher grade of ulcer.
Article
Skeletal abnormalities commonly reported in both human and experimental diabetes include impaired linear growth and osteopenia. In the present study we examined the effect of diabetes and insulin therapy on collagen, the major protein constituent of extracellular matrix. Insulin-deficient diabetes was induced in growing rats by injection of 90 mg/kg of streptozotocin. Articular cartilage and long bone (femur) were removed, and tissues incubated with [3H]-proline in vitro for 2 hours at 37 degrees C. Uptake of [3H]-proline into both collagen and noncollagen proteins was determined using purified bacterial collagenase. In cartilage, collagen production decreased to 46% of buffer-injected control animals within one week of induction of diabetes (p less than 0.01), and remained at this level for three weeks. A similar degree of suppression was found in long bone from untreated animals, in which collagen production decreased to 58% of control (p less than 0.01). Insulin administration at the onset of diabetes prevented the expected decrease in collagen production such that after one week of therapy, collagen production in bone and cartilage was 98% and 93% of control (p +/- 0.01 vs. untreated), respectively. When insulin therapy was delayed for one week after the induction of diabetes, collagen production in articular cartilage increased from 46% to 92% and 97% of control at the end of one and two weeks of therapy (p less than 0.01 vs. untreated), respectively. Noncollagen protein production in untreated rats decreased to 49% of control in long bone and to 72% of control in articular cartilage after one week (p less than 0.01), with correction to control levels in both tissues within one week of insulin therapy.(ABSTRACT TRUNCATED AT 250 WORDS)
Article
to describe the long-term outcome of local amputations and debridements of diabetic feet, with special reference to the presence or absence of arterial disease. a consecutive series of 75 diabetic patients having local foot surgery during 1987-92 was reviewed in 1998. A total of 136 operations had been done on 92 limbs, of which 52 (60%) had evidence of arterial disease. Survivors were interrogated in 1998, with follow-up intervals of 69-120 (median 92) months after their index operations. complete healing occurred in 48% feet, and 36% limbs required major amputation, after 1 day-7 years (median 24 days). Major amputation was more common in limbs with arterial disease (52% vs. 18%) -p;<0.001. At follow-up 20 (27%) patients were alive (five lost to long-term follow-up) - five of 44 (11%) arteriopaths, and 15 of 26 (58%) of those without arterial disease (p<0.001). No patient who had arterial reconstruction at the outset survived to follow-up. Among the survivors, 78% feet had remained healed, with no recurrent ulceration. among diabetics requiring local foot surgery, the presence of arterial disease confers a poor long-term prognosis for both life and limb. Those with neuropathy alone tend to do well with good foot care.
Management of diabetic foot
  • S Gupta
Gupta S. Management of diabetic foot. Medicine Update. 2012;22:28793.
Reducing diabetic foot problems and limb amputation: An experiencefrom India
  • S Pendsey
Pendsey S. Reducing diabetic foot problems and limb amputation: An experiencefrom India. In: Dinh T, editor. Global Perspective on Diabetic Foot Ulcerations. Croatia: InTech; 2011. Pp. 15-24.